Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.
Business Model:
Revenue: $6.4M
Employees: 2-10
Address: 645 Madison Ave
City: New York
State: NY
Zip: 10022
Country: US
Aperture Venture Partners is a venture capital group committed to working with exceptional entrepreneurs to tackle significant problems and create major new opportunities. They work with companies across a variety of sectors, primarily within the healthcare and healthy living industries. Their initial investment size ranges between $1 million and $5 million and they invest nationally. Their principals have been entrepreneurial leaders in the healthcare and investment industries over the past 30 years. They have successfully invested more than $1 billion and founded companies that have had combined revenues greater than $1 billion.
Contact Phone:
+12127587325
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2007 | MAKO Surgical | Series C | 0 |
8/2011 | Ceptaris Therapeutics | Series D | 14.4M |
6/2012 | Ceptaris Therapeutics | Series D | 10M |
3/2023 | Shoulder Innovations | Series D | 0 |
7/2017 | Trevi Therapeutics | Series C | 30M |
5/2013 | Channel Medsystems | Series B | 9.8M |
1/2020 | Cortica | Venture Round | - |
11/2018 | Cortica | Venture Round | - |
1/2021 | Neuros Medical | Series B | 0 |
9/2015 | Aclaris Therapeutics | Series C | 40M |
5/2010 | CardioMEMS | Venture Round | 0 |
10/2009 | CardioMEMS | Series F | 0 |
4/2015 | Spirox | Series B | 18.5M |
3/2004 | TransMolecular | Series C | 0 |
8/2017 | Neuros Medical | Series A | 20M |
3/2016 | Spirox | Series C | 45M |
4/2023 | Cortica | Series D | 0 |
8/2017 | Channel Medsystems | Series C | 0 |
9/2013 | Otonomy | Series C | 45.9M |
3/2014 | Axonics Modulation Technologies | Series A | 32.6M |
2/2015 | Lyricpharma | Series A | 20.4M |
7/2005 | Altea Therapeutics | Series C | 30M |
12/2013 | Xlumena | Series C | 0 |
4/2011 | Xlumena | Series B | 0 |
10/2019 | Verix Health | Series A | 0 |
2/2022 | Nalu Medical | Venture Round | 0 |
7/2004 | Nina McLemore | Venture Round | 3.7M |
2/2017 | Bristol Myers Squibb | Post-IPO Equity | 80M |
7/2016 | Endotronix | Series C | 0 |
3/2015 | Cardiac Dimensions | Equity | 15.2M |
9/2018 | Endotronix | Series D | 0 |
1/2007 | Ception Therapeutics | Series C | 63M |
9/2020 | Cardiac Dimensions | Series C | 17.5M |
7/2009 | Interlace Medical | Series C | 20.5M |
8/2005 | MAKO Surgical | Series B | 0 |
3/2015 | Collegium Pharmaceutical | Private Equity Round | 0 |
5/2022 | XII Medical | Series A | 0 |
5/2014 | Inspire Medical Systems | Series E | 0 |
7/2005 | TherOx | Venture Round | 30M |
4/2018 | V-Wave | Series C | 0 |
9/2015 | Channel Medsystems | Series C | 0 |
11/2003 | Redpoint Bio | Series A | 0 |
7/2011 | Avedro | Series C | 0 |
9/2020 | V-Wave | Series C | 0 |
3/2013 | Avedro | Series D | 0 |
4/2018 | Cardiac Dimensions | Series B | 39M |
4/2019 | Bardy Diagnostics | Series B | 35.5M |
12/2005 | Altea Therapeutics | Series C | 32.8M |
2/1992 | Metra Biosystems | Venture Round | 0 |
6/2021 | Cortica | Series C | 60M |
12/2021 | PetDx | Series B | 62M |
10/2019 | ShiraTronics | Series A | 0 |
1/2020 | Tarsus Pharmaceuticals | Series B | 60M |
5/2022 | XII Medical | Series A | 0 |
2/2022 | Nalu Medical | Venture Round | 0 |
12/2021 | PetDx | Series B | 0 |
6/2021 | Cortica | Series C | 0 |
1/2021 | Neuros Medical | Series B | 0 |
9/2020 | Cardiac Dimensions | Series C | 0 |
9/2020 | V-Wave | Series C | 0 |
1/2020 | Cortica | Venture Round | - |
1/2020 | Tarsus Pharmaceuticals | Series B | 0 |
10/2019 | ShiraTronics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|